Future studies are needed to analyze in depth the association of GARP expression with an expanded panel of putative GSC markers to further evaluate how universally and stably expressed GARP is on GSCs, and on different cellular components of the tumor microenvironment, especially those that are known to express GARP, like activated regulatory T cells and platelets. The gene discussed is LRRC32; the disease is neoplasm.